New drug slows down primary progressive MS for first time offering 'hope for future'

The drug ocrelizumab has been found to reduce the progression of Multiple Sclerosis by 25 per cent in people with primary progressive MS.
Source: Care Feeds

Our Office is Open from 9 am-5 pm Mon to Fri

ICare Nottingham Ltd

172 Derby Road,

Lenton Nottingham

NG7 1LR

T: 0115 9782403

Email: a.hussain@icarenottingham.co.uk

Email: recruitment@icarenottingham.co.uk

qcs
qcs
qcs